These lab-designed solutions were not developed with recreational use in your mind. Within the nineties, John W. Huffman plus a workforce of fellow chemists at Clemson College developed several of the first formulation for synthetic cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impact